Persistently Elevated mTOR Complex 1-S6 Kinase 1 Disrupts DARPP-32–Dependent D1 Dopamine Receptor Signaling and Behaviors

[1]  A. Grace,et al.  Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia , 2020, Frontiers in Psychiatry.

[2]  Gyu Hyun Kim,et al.  Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations , 2020, Nature Communications.

[3]  A. Law,et al.  Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development , 2020, Schizophrenia Research.

[4]  P. Magill,et al.  Tsc1-mTORC1 signaling controls striatal dopamine release and cognitive flexibility , 2019, Nature Communications.

[5]  F. Rigo,et al.  Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency , 2019, Nature Medicine.

[6]  M. Lobo,et al.  The Selective RhoA Inhibitor Rhosin Promotes Stress Resiliency Through Enhancing D1-Medium Spiny Neuron Plasticity and Reducing Hyperexcitability , 2019, Biological Psychiatry.

[7]  P. Ruisoto,et al.  The role of stress in drug addiction. An integrative review , 2019, Physiology & Behavior.

[8]  J. Bostwick,et al.  Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer’s Disease , 2018, Current Psychiatry Reports.

[9]  S. Thompson,et al.  Reward behavior is regulated by the strength of hippocampus-nucleus accumbens synapses , 2018, Nature.

[10]  M. Costa-Mattioli,et al.  mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors , 2018, Nature Neuroscience.

[11]  S. Hilsenbeck,et al.  Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice , 2018, The Journal of experimental medicine.

[12]  Jin-Young Park,et al.  Excessive D1 Dopamine Receptor Activation in the Dorsal Striatum Promotes Autistic-Like Behaviors , 2018, Molecular Neurobiology.

[13]  N. Pavletich,et al.  Structural Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40 , 2017, Nature.

[14]  M. Lobo,et al.  Molecular basis of dendritic atrophy and activity in stress susceptibility , 2017, Molecular Psychiatry.

[15]  David M. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[16]  M. Bennett,et al.  Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice , 2016, Proceedings of the National Academy of Sciences.

[17]  Aaron J. Bell,et al.  Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models , 2016, Front. Behav. Neurosci..

[18]  Masahiko Watanabe,et al.  Phosphoproteomics of the Dopamine Pathway Enables Discovery of Rap1 Activation as a Reward Signal In Vivo , 2016, Neuron.

[19]  P. J. Vries,et al.  Neurological and neuropsychiatric aspects of tuberous sclerosis complex , 2015, The Lancet Neurology.

[20]  Alexxai V. Kravitz,et al.  Nucleus Accumbens Medium Spiny Neuron Subtypes Mediate Depression-Related Outcomes to Social Defeat Stress , 2015, Biological Psychiatry.

[21]  J. Lipton,et al.  The Neurology of mTOR , 2014, Neuron.

[22]  E. Klann,et al.  Requirement of Mammalian Target of Rapamycin Complex 1 Downstream Effectors in Cued Fear Memory Reconsolidation and Its Persistence , 2014, The Journal of Neuroscience.

[23]  Raag D. Airan,et al.  Natural Neural Projection Dynamics Underlying Social Behavior , 2014, Cell.

[24]  M. Costa-Mattioli,et al.  mTOR complexes in neurodevelopmental and neuropsychiatric disorders , 2013, Nature Neuroscience.

[25]  R. Malenka,et al.  Social reward requires coordinated activity of accumbens oxytocin and 5HT , 2013, Nature.

[26]  R. Nixon,et al.  The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.

[27]  D. Linden,et al.  A Prolyl-Isomerase Mediates Dopamine-Dependent Plasticity and Cocaine Motor Sensitization , 2013, Cell.

[28]  Christos G. Gkogkas,et al.  Autism-related deficits via dysregulated eIF4E-dependent translational control , 2012, Nature.

[29]  E. Klann,et al.  Exaggerated Translation Causes Synaptic and Behavioral Aberrations Associated with Autism , 2012, Nature.

[30]  Jacqueline N. Crawley,et al.  Autistic-like behavior and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice , 2012, Nature.

[31]  Robert C. Malenka,et al.  Anhedonia requires MC4 receptor-mediated synaptic adaptations in nucleus accumbens , 2012, Nature.

[32]  M. Bear,et al.  Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice , 2012, Neuron.

[33]  E. Klann,et al.  Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex , 2012, Neurobiology of Disease.

[34]  Mark F. Bear,et al.  Mutations causing syndromic autism define an axis of synaptic pathophysiology , 2011, Nature.

[35]  D. Sabatini,et al.  The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling , 2011, Science.

[36]  R. Gainetdinov,et al.  The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.

[37]  G. Feng,et al.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction , 2011, Nature.

[38]  P. Worley,et al.  Rheb1 is required for mTORC1 and myelination in postnatal brain development. , 2011, Developmental cell.

[39]  D. Alessi,et al.  The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.

[40]  Wei Zhang,et al.  Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice , 2009, The Journal of Neuroscience.

[41]  Paul Greengard,et al.  Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs , 2008, Nature Neuroscience.

[42]  Alcino J. Silva,et al.  Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.

[43]  Paul Greengard,et al.  A phosphatase cascade by which rewarding stimuli control nucleosomal response , 2008, Nature.

[44]  Scott J. Russo,et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.

[45]  Angus C Nairn,et al.  Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56δ subunit , 2007, Proceedings of the National Academy of Sciences.

[46]  Jianhua Zhang,et al.  c-Fos Facilitates the Acquisition and Extinction of Cocaine-Induced Persistent Changes , 2006, The Journal of Neuroscience.

[47]  P. Calabresi,et al.  Chronic Cocaine Prevents Depotentiation at Corticostriatal Synapses , 2006, Biological Psychiatry.

[48]  Rebecca M. Jones,et al.  Hyperactivation of Mammalian Target of Rapamycin (mTOR) Signaling by a Gain-of-Function Mutant of the Rheb GTPase* , 2006, Journal of Biological Chemistry.

[49]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[50]  Steven P. Gygi,et al.  mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.

[51]  C Eng,et al.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations , 2005, Journal of Medical Genetics.

[52]  Angus C Nairn,et al.  Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Greengard,et al.  Diverse Psychotomimetics Act Through a Common Signaling Pathway , 2003, Science.

[54]  H. Braak,et al.  Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. , 2003, The American journal of pathology.

[55]  P. Greengard,et al.  Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[57]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.